Description

Alexandrescu et al reported secondary erythrocytosis in oncology patients treated with tyrosine kinase inhibitors (TKI). The authors are from Georgetown University, Washington Hospital Center, the Mayo Clinic, and Group Health in Seattle, Washington.

To read more or access our algorithms and calculators, please log in or register.